Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000874015-14-000031
Filing Date
2014-02-05
Accepted
2014-02-05 18:30:29
Documents
2
Period of Report
2014-02-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2245
2 loscalzopoa.htm EX-24 3055
  Complete submission text file 0000874015-14-000031.txt   6499
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
LOSCALZO JOSEPH (Reporting) CIK: 0001276128 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19125 | Film No.: 14577466